Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| HOOKIPA Pharma Inc | HOOK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.7649 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7649 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.41 - 2.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.7649 | USD |
HOOKIPA Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.8M | 83.95M | - | 20.13M | -81.58M | -0.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
HOOKIPA Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOOK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.81 | 0.90 | 0.712 | 0.778539 | 550,918 | -0.0451 | -5.57% |
| 1 Month | 0.75 | 0.90 | 0.6996 | 0.7770246 | 549,392 | 0.0149 | 1.99% |
| 3 Months | 0.7081 | 0.90 | 0.5789 | 0.7237804 | 551,077 | 0.0568 | 8.02% |
| 6 Months | 0.55 | 1.13 | 0.41 | 0.7792328 | 1,511,094 | 0.2149 | 39.07% |
| 1 Year | 0.77 | 2.05 | 0.41 | 0.9150441 | 1,214,401 | -0.0051 | -0.66% |
| 3 Years | 12.52 | 20.00 | 0.41 | 2.00 | 1,200,592 | -11.76 | -93.89% |
| 5 Years | 14.00 | 20.00 | 0.41 | 2.43 | 755,586 | -13.24 | -94.54% |
HOOKIPA Pharma Description
| HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. |
